B.J. Potter van Loon

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance

B.J. Potter van Loon, Cornelis Kluft, J.K. Radder et al. · Metabolism · 1993 · 226 citations

Insulin Resistance, Metabolic Syndrome, Hypertension +13

Simplification of the Diagnostic Management of Suspected Deep Vein Thrombosis

Roderik A. Kraaijenhagen, Franco Piovella, Enrico Bernardi et al. · Archives of Internal Medicine · 2002 · 191 citations

Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus

Barbera van Harten, Joukje M. Oosterman, D. Muslimović et al. · Age and Ageing · 2007 · 169 citations · Full text

Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial

Daphne N. Voormolen, J. Hans DeVries, Rieneke M. E. Sanson et al. · Diabetes Obesity and Metabolism · 2018 · 143 citations · Full text

The Amount of Plasminogen, Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 in Human Thrombi and the Relation to IVVO-TNO Lysibility

B.J. Potter van Loon, D.C. Rijken, E.J.P. Brommer et al. · Thrombosis and Haemostasis · 1992 · 94 citations

Pharmacotherapy, Biomedical Engineering, Thrombosis +18